T 0033/19 (Eculizumab for use in treating aHUS/ALEXION) of 22.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T003319.20210422
- Date of decision
- 22 April 2021
- Case number
- T 0033/19
- Online on
- 1 June 2021
- Petition for review of
- -
- Application number
- 15152757.9
- IPC class
- C07K 16/18
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods and compositions for treating complement-associated disorders
- Applicant name
- Alexion Pharmaceuticals, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 83EPC2000 Art 111(1) Sentence 2Rules of procedure of the Boards of Appeal Art 11Rules of procedure of the Boards of Appeal Art 12(2)
- Keywords
- Sufficiency of disclosure - (yes)
Inventive step - reasonable expectation of success (no)
Appeal decision - remittal to the department of first instance (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution.